BIOSTAR PHARM-B(02563): The China Securities Regulatory Commission has issued a filing notice for the company's full circulation of shares.
Hua Hao Zhongtian Pharmaceuticals-B (02563) announces that the company has received a filing notice from the China Securities Regulatory Commission regarding the application for filing on February 5, 2026. According to the filing notice, the company has completed the filing with the China Securities Regulatory Commission for the implementation of the full circulation of H shares. The filing notice will be valid for 12 months from the date of issuance. The company will apply for conversion and listing on the Hong Kong Stock Exchange.
BIOSTAR PHARM-B (02563) announced that the company has received a record notice from the China Securities Regulatory Commission on February 5th, 2026. According to the record notice, the company has filed with the China Securities Regulatory Commission for the implementation of H-share circulation. The record notice will be valid for 12 months from the date of issuance. The company will apply to the Stock Exchange for conversion and listing.
As of the date of this announcement, the details of the implementation plan for conversion and listing have not been finalized. The company will make further announcements regarding the progress and details of the conversion and listing in accordance with the listing rules and applicable laws at the appropriate time.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
